C0003241||anti-red blood cell IgG-Fc alloantibody
C0014761||haemolytic disease of the fetus and newborn
C0014761||Haemolytic disease of the fetus and newborn
C0014761||Haemolytic disease of the fetus and newborn
C0012634||disease
C0015965||fetal
C0014792||red blood cells
C0014792||red blood cells
C0729663||maternal anti-RBC IgG alloantibodies
C0014761||Haemolytic disease of the fetus and newborn
C0140430||anti-D
C0313239||anti-K
C0432626||-c
C0947659||-E
C1622430||N-linked glycosylation
C0140430||anti-D
C3271553||fucosylation
C0003255||affinity
C1521898||IgG-Fc receptor IIIa
C0966831||IIIb
C0014761||Haemolytic disease of the fetus and newborn
C0012634||disease
C0033011||pregnant women
C0432626||anti-c
C0947659||-E
C0313239||-K
C0022144||alloantibodies
C0422390||screening cohort
C0376322||Fc-tail glycosylation
C0003241||antibodies
C0020971||immunisation
C0032972||pregnancy outcome
C0432626||Anti-c
C0947659||-E
C0313239||-K
C0020971||immunisation
C0376322||Fc-glycosylation
C0020852||IgG fraction
C0140430||anti-D
C1159287||Fc-galactosylation
C4235385||sialylation
C0432626||anti-c
C0014761||Haemolytic disease of the fetus and newborn
C0012634||disease
C0313239||anti-K
C1159287||Fc-fucosylation
C2349595||fetal anaemia
C0376322||IgG-Fc glycosylation
C0003241||anti-RBC antibodies
C0003320||antigen